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Background: Candida albicans is a diploid yeast that in some circumstances may cause oral or oropharyngeal
infections. Yeasts virulence factors contribute for both the maintenance of colonizing strains in addition to damage
and cause tissue invasion, thus the establishment of infection occurs. The limited arsenal of antifungal drugs for the
treatment of candidiasis turn the investigation of natural products mandatory for the discovery of new targets for
antifungal drug development. Therefore, tropical countries emerge as important providers of natural products with
potential antimicrobial activity. This study aimed to investigate morphogenesis and secretion of hydrolytic enzymes
(phospholipase and proteinase) in the presence of the CE of Eugenia uniflora.
Methods: The isolates were tested for their ability to form hyphae in both solid and liquid media under three
different conditions: YPD + 20% FBS, Spider medium and GlcNac and the ability to secrete phospholipase and
proteinase in the presence of 2000 μg/mL of E. uniflora.
Results: The CE of E. uniflora inhibited hypha formation in both liquid and solid media tested. It also impaired
hydrolytic enzymes production.
Conclusions: This was the first study to describe the interaction of a natural product with the full expression of
three different factors in C. albicans. E. uniflora may be an alternative therapeutic for oral candidiasis in the future.
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Eugenia unifloraBackground
Candida species are the most common human fungal
pathogens, whereas Candida albicans is the most preva-
lent species isolated in fungal infections of the oral mu-
cosa [1-3]. In the human oral cavity, these yeasts colonize
from 20 to 80% of adults without evidences of infection
[3-5]. However, in some circumstances which involve both
pathogen attributes of virulence as well as host immunity;* Correspondence: guilherme.chaves@ufrnet.br
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unless otherwise stated.specific groups of patients, such as those with AIDS,
transplant recipients and patients submitted to broad
spectrum antibiotics may become susceptible to de-
velop oropharyngeal candidiasis [6-8].
Oral candidiasis is a fungal opportunistic infection com-
monly observed in kidney transplant recipients, where the
prevalence of the disease ranges from 9.4 to 46% in differ-
ent group of patients, being C. albicans the most fre-
quently isolated species [6,9-13].
C. albicans virulence factors contribute for both the
maintenance of colonizing strains and tissue invasion, thus
the establishment of infection occurs [14-16]. Among the
main virulence attributes of C. albicans are the ability oftral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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called morphogenesis, which contributes to tissue invasion
[17]. Morphogenesis is a well-recognized virulence factor
in C. albicans, because mutants unable to form pseudohy-
phae or true hyphae are attenuated in virulence [18,19].
Merson-davies and Odds [20] proposed a quantitative
index based on the shape of the cells to differentiate blas-
toconidia, pseudohyphal and true hyphal forms of growth.
Yeast cells have a morphology index (MI) between 1.0 to
1.5, pseudo hyphae from 2.5 to 3.4 and true hyphae
greater than 3.4 [21]. This index, based on a complex
image analysis measurements can be substituted with an
approximated score system to generate information on
morphology distributions [22,23].
The secretion of hydrolytic enzymes such as phospholi-
pases, which degrade glycerolphospholipids of cell mem-
branes, is important for host cells destruction [24]. In
addition, C. albicans possesses secreted aspartic pro-
teinases (Saps), able to target several important substrates,
such as albumin, immunoglobulins and extracellular
matrix proteins [14,25,26].
The limited arsenal of antifungal drugs for the treat-
ment of candidiasis includes mainly polyenes, azoles and
echinocandins [27-29]. Nevertheless, these drugs have
narrow therapeutic index, low bioavailability, week intes-
tinal absorption and serious side effects [30]. In addition,
the excessive and indiscriminate use of antifungal agents
favors the development of resistant strains [31]. Although
C. albicans has been reported as less resistant to antifun-
gal drugs than other Candida species, resistance to azoles
[32] and echinocandins [33] have been reported. There-
fore, due to the increase of resistance of pathogenic fungi
to antifungal drugs currently used, there is a necessity for
the prevention of oral fungal infections and the develop-
ment of alternative therapies [34,35].
The use of natural products aiming the treatment of
several diseases has increased in the last few years, related
to the high diversity of plants distributed around the
planet [36]. Nevertheless, there are only a few studiesFigure 1 Candida albicans SC5314 pre-cultivated in NGY broth in the
30°C of incubation. Blastoconidia show cell wall damage and large vacuoabout the use of vegetal extracts to treat fungal infec-
tions, including candidiasis [37-39]. In addition, very little
is known about the action of plant extractive compounds
in the virulence attributes of C. albicans.
Concerning to the world biodiversity, the American
flora is one of the most rich source of plants with
pharmacological activities [40] In this context, Brazil
emerges as an important provider of botanical material
for the international pharmaceutical market [40]. Eugenia
uniflora, (known in Brazil as “pitangueira”) is a native
Brazilian plant belonging to the family Myrtaceae,
which includes species that have phenolic compounds
as the predominant constitution [41]. The infusion of
E. uniflora leaves has application in popular medicine
mainly due to its properties as antioxidant, hypotensive,
modulator of antibiotics and antifungal drugs [42]. Actu-
ally, anti-Candida activity of E. uniflora has been previ-
ously described [42,43].
The present study aimed to evaluate the action of the
crude extract (CE) of E. uniflora in some C. albicans
virulence factors, including morphogenesis and hydro-
lytic enzymes (proteinase and phospholipase) activities
of clinical oral isolates of C. albicans obtained from kid-
ney transplant recipients in Brazil.
Methods
Plant material and Eugenia uniflora extract
E. uniflora leaves were collected in Ceará-Mirim city, in
the east of Rio Grande do Norte state, Brazil. The plant
was identified at the Herbarium of the Federal University
of Rio Grande do Norte (Department of Botany, Ecology
and Zoology, Biosciences Center), and a voucher speci-
men was deposited (n° 11763). The leaves were dried at
room temperature and ground into powder. Subsequently,
10 g of the dried leaves powder was submitted to turbo
extraction with 100 mL of acetone:water (7:3, v/v), in four
rounds of five minutes. The resulting extract was filtered
and concentrated by rotary evaporation at 40°C, 150 rpm
(Laborota 4000, Heidolph). The concentrated was submittedpresence of 2000 μg/ml of the CE of E. uniflora for 24 h, 200 rpm,
les (400x magnification).
Table 1 Mean morphology index (MI) of Candida albicans clinical isolates obtained from the oral cavity of kidney
transplant recipients after 3 h of incubation in liquid media at 37°C, 200 rpm
YPD+ 20% Fetal Bovine Serum Spider broth N-acetyl-D-glucosamine broth
Strain Absence of CE vs. Presence of CE* Absence of CE vs. Presence of CE* Absence of CE vs. Presence of CE*
ATCC90028 3.82 ± 0.50 vs. 2.47 ± 0.69 2.75 ± 1.46 vs. 1.03 ± 0.30 2.72 ± 0.96 vs. 2.08 ± 0.42
SC5314 3.28 ± 0.81 vs. 2.19 ± 0.68 3.52 ± 1.09 vs. 1.88 ± 1.37 2.59 ± 0.83 vs. 2.02 ± 0.79
Strain01 2.46 ± 0.70 vs. 3 ± 0.74 3.03 ± 0.95 vs. 1.38 ± 0.92 2.69 ± 0.81 vs. 2.14 ± 0.67
Strain02 3.43 ± 0.77 vs. 2.71 ± 0.87 2.9 ± 1.34 vs. 1.95 ± 0.76 2.06 ± 0.28 vs. 2.24 ± 0.57
Strain03 3.22 ± 0.64 vs. 2.47 ± 0.69 2.25 ± 0.66 vs. 0.95 ± 0.66 2.62 ± 0.74 vs. 2.28 ± 0.62
Strain05 2.23 ± 0.57 vs. 2.51 ± 0.59 2.75 ± 1.24 vs. 1.36 ± 0.88 2.09 ± 0.44 vs. 1.92 ± 0.49
Strain06 2.24 ± 0.51 vs. 2.08 ± 0.27 3.29 ± 1.12 vs. 1.39 ± 0.69 1.93 ± 0.33 vs. 1.91 ± 0.45
Strain08 1.86 ± 0.43 vs. 2 ± 0 3.57 ± 1.01 vs. 2.27 ± 1.46 2.01 ± 0.10 vs. 1.8 ± 0.40
Strain10 2.17 ± 0.62 vs. 2.7 ± 0.7 2.69 ± 1.36 vs. 1.69 ± 1.22 2.1 ± 0.54 vs. 1.98 ± 0.45
Strain11 2.15 ± 0.77 vs. 2.41 ± 0.57 3.62 ± 0.83 vs. 1.05 ± 0.51 2.49 ± 0.73 vs. 2.09 ± 0.57
Strain12 2.46 ± 0.56 vs. 2.32 ± 0.55 2.2 ± 0.74 vs. 1.11 ± 0.53 2.48 ± 0.61 vs. 2.03 ± 0.50
Strain13 2.17 ± 0.65 vs. 2.33 ± 0.57 2.99 ± 1.18 vs. 1.46 ± 0.99 2.26 ± 0.75 vs. 2 ± 0.59
Strain17 3.38 ± 0.63 vs. 1.82 ± 0.81 2.45 ± 0.83 vs. 1.24 ± 0.67 2.69 ± 0.79 vs. 2.34 ± 0.45
Strain20 3.7 ± 0.81 vs. 2.33 ± 0.57 3 ± 0.99 vs. 1.12 ± 0.52 3.55 ± 0.74 vs. 2.89 ± 0.85
Strain21 2.7 ± 0.92 vs. 2.58 ± 0.85 2.63 ± 1.28 vs. 1.57 ± 1.15 3.67 ± 0.53 vs. 3.21 ± 0.78
Strain23 2.8 ± 0.67 vs. 2.73 ± 0.61 2.07 ± 0.48 vs. 1.12 ± 0.59 2.3 ± 0.59 vs. 1.88 ± 0.52
Strain24 2.81 ± 0.74 vs. 1.8 ± 0.47 2.12 ± 0.54 vs. 1.25 ± 0.44 3.3 ± 0.78 vs. 2.73 ± 0.98
Strain28 3.24 ± 0.80 vs. 2.28 ± 0.53 1.64 ± 0.94 vs. 1.31 ± 0.90 3.54 ± 0.63 vs. 3.1 ± 0.87
Strain30 2 ± 0.62 vs. 2.32 ± 0.60 2.21 ± 0.46 vs. 1.1 ± 0.36 3.59 ± 0.62 vs. 3.25 ± 0.97
Strain31 2.79 ± 0.82 vs. 2.41 ± 0.48 2.2 ± 0.53 vs. 1.57 ± 0.70 3.63 ± 0.71 vs. 2.99 ± 0.82
Strain32 1.8 ± 0.65 vs. 2.2 ± 0.52 3.85 ± 0.48 vs. 2.33 ± 0.68 3.68 ± 0.49 vs. 3.1 ± 0.73
Strain34 2.15 ± 0.64 vs. 2.05 ± 0.50 2.6 ± 0.67 vs. 1.22 ± 0.52 3.57 ± 0.71 vs. 3.28 ± 0.74
Strain37 3.63 ± 0.80 vs. 2.87 ± 0.44 2.83 ± 0.79 vs. 1.2 ± 0.40 3.06 ± 0.83 vs. 3.36 ± 0.80
Strain40 2.85 ± 0.56 vs. 2.34 ± 0.68 1.98 ± 0.14 vs. 1.92 ± 0.27 3.79 ± 0.48 vs. 3.39 ± 0.65
Strain41 2.78 ± 0.69 vs. 2.3 ± 0.71 2.25 ± 0.52 vs. 1.79 ± 0.52 3.48 ± 0.77 vs. 2.99 ± 0.85
Strain44 2.45 ± 0.77 vs. 2.36 ± 0.83 2.07 ± 0.26 vs. 1.46 ± 0.50 2.15 ± 0.36 vs. 1.19 ± 0.61
Strain46 3.05 ± 0.77 vs. 2.23 ± 0.45 2.32 ± 0.57 vs. 1.52 ± 0.70 2.16 ± 0.47 vs. 1.96 ± 0.57
Strain50 2.84 ± 0.88 vs. 2.31 ± 1.01 2.99 ± 0.72 vs. 1.3 ± 0.46 2.49 ± 0.67 vs. 1.35 ± 0.70
Strain51 2.17 ± 0.43 vs. 2.14 ± 0.53 2.21 ± 0.46 vs. 1.2 ± 0.49 3.88 ± 0.38 vs. 1.41 ± 0.84
Strain53 2.64 ± 0.71 vs. 2.49 ± 0.67 2.36 ± 0.33 vs. 1.43 ± 0.73 2.07 ± 0.38 vs. 1.92 ± 0.42
Strain54 2.81 ± 0.40 vs. 2.34 ± 0.45 2.88 ± 0.82 vs. 1.6 ± 0.49 2.23 ± 0.51 vs. 1.19 ± 0.49
Strain60 2.36 ± 0.36 vs. 2.22 ± 0.26 1.88 ± 0.33 vs. 1.29 ± 0.67 2.41 ± 0.49 vs. 1.06 ± 0.24
Strain61 2.48 ± 0.75 vs. 1.71 ± 0.48 2.1 ± 0.39 vs. 1.08 ± 0.26 2.42 ± 0.61 vs. 1.05 ± 0.22
Strain70 2.99 ± 0.50 vs. 2.37 ± 0.49 2.54 ± 0.77 vs. 1.63 ± 1.05 2.53 ± 0.61 vs.1.21 ± 0.41
Strain72 2.31 ± 0.61 vs. 2.27 ± 0.51 2.37 ± 0.73 vs. 1.33 ± 0.70 2.72 ± 0.65 vs. 1.44 ± 0.69
Strain82 3.36 ± 0.93 vs. 2.62 ± 0.60 2.39 ± 0.58 vs. 1.31 ± 0.65 3.8 ± 0.60 vs. 1.47 ± 1.02
Strain85 3.15 ± 0.83 vs. 2.25 ± 0.63 1.98 ± 0.14 vs. 1.06 ± 0.31 2.77 ± 0.68 vs. 1.4 ± 0.53
Strain107 2.39 ± 0.63 vs. 2.19 ± 0.39 2.07 ± 0.33 vs. 1.06 ± 0.34 2.08 ± 0.31 vs. 1.27 ± 0.45
Strain06A 2.34 ± 0.71 vs. 2.1 ± 0.58 2.38 ± 0.68 vs. 1.6 ± 0.83 2.45 ± 0.59 vs. 1.53 ± 0.63
Strain06L 2.94 ± 0.58 vs. 2.56 ± 1.01 2.28 ± 0.59 vs. 1.52 ± 0.67 3.86 ± 0.45 vs. 1.13 ± 0.43
Strain10Li 2.42 ± 0.70 vs. 2.29 ± 0.62 2.01 ± 0.17 vs. 1.03 ± 0.17 2.42 ± 0.74 vs. 1.07 ± 0.29
Strain10S 2.54 ± 0.76vs. 2.65 ± 0.69 2.06 ± 0.55 vs. 1.02 ± 0.14 2.55 ± 0.86 vs. 1.12 ± 0.46
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Table 1 Mean morphology index (MI) of Candida albicans clinical isolates obtained from the oral cavity of kidney
transplant recipients after 3 h of incubation in liquid media at 37°C, 200 rpm (Continued)
Strain12A 3.3 ± 0.79 vs. 2.44 ± 0.80 2.04 ± 0.20 vs. 1.09 ± 0.32 2.62 ± 0.74 vs. 1.16 ± 0.44
Strain12L 3.2 ± 0.68 vs. 2.31 ± 0.63 1.96 ± 0.20 vs. 1.09 ± 0.29 2.43 ± 0.59 vs. 1.19 ± 0.49
Strain15A 2.96 ± 0.83 vs. 2.38 ± 0.84 2.21 ± 0.46 vs. 1.2 ± 0.49 3.12 ± 0.87 vs. 1.11 ± 0.35
Strain15G 3.13 ± 0.81 vs. 1.92 ± 0.76 1.85 ± 0.36 vs. 1.26 ± 0.61 3.63 ± 0.61 vs. 1.4 ± 0.82
Strain15L 2.58 ± 0.68 vs. 2.34 ± 0.76 2.85 ± 0.89 vs. 1.3 ± 0.90 3.03 ± 0.89 vs. 1.63 ± 0.61
Strain18A 3.05 ± 0.67 vs. 1.74 ± 0.52 2.3 ± 0.56 vs. 1.53 ± 0.67 2.47 ± 0.64 vs. 1.97 ± 0.72
Strain111L 2.6 ± 0.70 vs. 2.36 ± 0.54 1.92 ± 0.42 vs. 1.26 ± 0.58 3.12 ± 0.57 vs. 1.33 ± 0.59
Strain111R 4 ± 0 vs. 3.11 ± 0.89 2.21 ± 0.46 vs. 1.21 ± 0.50 3.83 ± 0.53 vs. 3.55 ± 0.74
*CE: Crude Extract of Eugenia uniflora (2000 μg/mL).
Cells were either pre-cultivated in NGY broth in the absence (control experiments) or presence of 2000 μg/ml (test experiments) of the CE of Eugenia uniflora for
24 h, 200 rpm, 30°C of incubation, previously to the filamentation induction experiments. One hundred cells of each strain were scored.
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Fisher Scientific, France) and the extract was stored at 4°C.Strains and culture conditions
We evaluated a total of 48 C. albicans clinical isolates
obtained from the oral cavity of kidney transplant recipi-
ents, belonging to the Medical and Molecular Mycology
Laboratory, Department of Clinical and Toxicological
Analyses, Federal University of Rio Grande do Norte.
Only patients who agreed to take part on a surveillance
confidential study, in accordance to the Local Research
Ethics committee from The Onofre Lopes University
Hospital, approved under the number 152/07, were en-
rolled in this study. Two references strains, C. albicansFigure 2 Candida albicans 111R, a highly filamentous strain obtained
incubation in YPD + 20% FBS (A), Spider (B) and GlcNac (C) liquid med
the absence (control experiments; lane 1) or presence of 2000 μg/ml (test
30°C of incubation, previously to the filamentation induction experimenATCC90028 and C. albicans SC5313 were used as con-
trol organisms. All the strains were cultivated on the
surface of Sabouraud Dextrose Agar (Dextrose 40 g,
Peptone 10 g, Agar 15 g, Distilled water 1000 mL) and in-
cubated at 37°C for 48 h before the experiments. The
strains were stored in YPD broth (Dextrose 2 g, Peptone 2 g,
Yeast extract 1 g, and Distilled Water, 100 mL) with
20% glycerol at -80°C.Inoculum standardization for Candida albicans virulence
factors evaluated “in vitro”
For all the virulence factors evaluated in vitro, the samples
were initially grown in NGY medium (Difco Neopeptone
1 g/L, Dextrose 4 g/L; Difco yeast extract 1 g/L). C. albicansfrom the oral cavity of a kidney transplant recipient after 3 h of
ia at 37°C, 200 rpm. Cells were either pre-cultivated in NGY broth in
experiments; lane 2) of the CE of Eugenia uniflora for 24 h, 200 rpm,
ts.
Table 2 Measurements Candida albicans hyphal sizes of
clinical isolates obtained from the oral cavity of kidney
transplant recipients after 3 h of incubation in liquid
media at 37°C, 200 rpm
Hyphal size (μm)
Strain Abscence of CE** vs. Presence of CE**
ATCC 90028 24.68 (24.68 ± 1.79) vs. 13.35 (13.35 ± 0.92)*
SC5314 30 (30 ± 2.47) vs. 16 (16 ± 1.16)*
Strain 01 21.67 (21.67 ± 1.39) vs. 15.02 (15.02 ± 1. 28)*
Strain 05 22.84 (22.84 ± 1.68) vs. 18.17 (18.17 ± 2.12)
Strain 06 19.3 (19.3 ± 1.23) vs. 11.24 (11.24 ± 1.79)*
Strain 12 10.16 (10.3 ± 1.89) vs. 16.62 (16.62 ± 1.34)
Strain 23 16.81 (16.81 ± 2.12) vs. 11.08 (11.08 ± 0,76)
Strain 30 10.06 (10.06 ± 0.86) vs. 14.32 (14.32 ± 0.97)
Strain 37 23.21 (23.21 ± 1.83) vs. 18.55 (18.55 ± 1. 48)*
Strain 40 23.28 (23.28 ± 1.94) vs. 13.6 (13.6 ± 0.91)*
Strain 54 15.35 (15.35 ± 1.41) vs. 3 (3 ± 0.32)*
Strain 10Li 21.25 (21.25 ± 1.87) vs. 11.73 (11.73 ± 0.92)*
Strain 111R 36.15 (36.15 ± 2.56) vs. 25.06 (25.06 ± 1.34)*
*P < 0.05, **CE: Crude Extract of Eugenia uniflora (2000 μg/mL).
Cells were either pre-cultivated in NGY broth in the absence (control experiments)
or presence of 2000 μg/ml (test experiments) of the CE of Eugenia uniflora for 24 h,
200 rpm, 30°C of incubation, previously to the filamentation induction experiments.
One hundred cells of each strain were scored.
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(Tecnal, TE-420, São Paulo, Brazil) at 30°C, 200 rpm.
This culture medium produces an inoculum size of
about 2 × 108 cells/mL, spectrophotometrically measured
at a wavelength of 600 nm (Biochrom Libra S21/S22 spec-
trophotometer; [22]). Subsequently, C. albicans cells were
diluted to obtain the specific inoculums needed for each
attribute of virulence test evaluated in vitro.
Micromorphological analysis of Candida albicans cells
grown in NGY broth in the presence of Eugenia uniflora
For comparative purposes, C. albicans cells grown in
NGY broth supplemented with 2000 μg/ml of the CE of
E. uniflora (as previously described) were observed under
an optical microscope (CX21, Olympus, Japan) and the
micromorphological aspect of the cells was observed at
400x magnification.
Morphogenesis of Candida albicans in YPD broth added 20%
fetal bovine serum, spider broth and n-acetyl-d-glucosamine
broth (GlcNac)
The morphogenesis assay was performed according to
the technique described by Chaves et al. [22]. C. albicans
cells were standardized to 1×106 cells/mL and subse-
quently inoculated into three distinct morphogenesis in-
duction culture media: YPD broth added Fetal BovineSerum (Sigma- Aldrich) at a concentration of 20%, Spider
broth (nutrient broth 1 mL, mannitol 1 g, dibasic potassium
phosphate 0.2 g, destilated water 99 mL, pH 7.5), and
GlcNac broth (Yeast Nitrogen Base -Difco®- 6.7 g, N-acetyl-
d-glucosamine-Himedia®- 20g, destilated water 1000 mL)
and then incubated during 3 h at 37°C - 200 rpm in a rota-
tory shaker in the presence and absence of 2000 μg/ml of
the CE of E. uniflora. After 3-h incubation, culture samples
were mixed with an equal volume of 10% formaldehyde to
arrest further development. The 3-h sample was exam-
ined to approximate the mean morphology index (MI),
in which a value close to 1 indicates a population of
spheroidal yeast cells and value close to 4 indicates a
population of true hyphal cells. Values between 2.5 to
3.4 indicate pseudohyphal morphologies. One hundred
cells of each strain were scored.
Measurements of Candida abicans hyphal cells length
C. albicans cells length was measured after morphogenesis
induction (3h incubation in YPD + 20% FBS). For this pro-
posal, the Tsview software® (Eclipse E100, Nikon, Japan)
was employed. For each strain, the mean of 100 hyphal
cells length was determined for the isolates previously
grown in the presence or the absence of E. uniflora.
Morphogenesis of Candida albicans on solid media
For the induction of hyphal formation on solid media,
the cells were grown in NGY, centrifuged and washed
three times in water. From the cell suspensions, 5 μL
was spotted on the surface of Spider medium (Nutrient
agar 10 g, Mannitol 10 g, KH2PO4 2 g, agar 14.5 g, Distilled
water 1000 mL [44]) and GlcNac medium (Yeast Nitrogen
Base -Difco®- 6,7 g, N-acetyl-d-glucosamine-Himedia®- 20 g,
agar 20 g, destilated water 1000 mL) in the presence and ab-
sence of 2000 μg/ml of the CE of E. uniflora. Alternatively,
cells were also grown on the surface of YPD + 20% FBS agar,
as previously described for Spider Medium. The plates were
incubated at 30°C for seven days for subsequent observation
of macromorphological aspects of the colonies. The assay
was performed in triplicate.
Candida albicans phospholipase assay
Phospholipase activity was determined with the method of
Price et al. [45]. NGY overnight cultures were standardized
to an inoculum size of 2×105 cells/ml, and five μL of the cell
suspension was inoculated in triplicate on the surface of
phospholipase agar (10 g peptone, 40 g dextrose, 16 g agar,
Egg Yolk Emulsion (Fluka) was added 80 mL, Distilled water
1000 mL) in the presence and absence of 2000 μg/ml of the
CE of E. uniflora (10 g peptone, 40 g dextrose, 16 g agar,
Egg Yolk Emulsion 80 mL, CE of E. uniflora 2000 μg/mL,
Distilled water 1000 mL). The plates were incubated
for 72 h at 30°C. After the incubation period, the
Table 3 Hypha formation on solid media of Candida albicans clinical isolates obtained from the oral cavity of kidney
transplant recipients
YPD+ 20% Fetal Bovine Serum Spider medium N-acetyl-D-glucoasmine medium
Strain Absence of CE* vs. Presence of CE* Absence of CE* vs. Presence of CE* Absence of CE* vs. Presence of CE*
ATCC90028 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
SC5314 Wrinkled vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Wrinkled
Strain01 Smooth vs. Smooth Wrinkled vs. Smooth Smooth vs. Smooth
Strain02 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain03 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain05 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain06 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain08 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain10 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain11 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain12 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain13 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain17 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain20 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain21 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain23 Smooth vs. Smooth Smooth vs. Smooth Wrinkled vs. Smooth
Strain24 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain28 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain30 Smooth vs. Smooth Smooth vs. Smooth Wrinkled vs. Smooth
Strain31 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain32 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain34 Smooth vs. Smooth Wrinkled vs. Smooth Smooth vs. Smooth
Strain37 Smooth vs. Smooth Wrinkled vs. Smooth Smooth vs. Smooth
Strain40 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain41 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain44 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain46 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain50 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain51 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain53 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain54 Smooth vs. Smooth Wrinkled vs. Smooth Smooth vs. Smooth
Strain60 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Wrinkled
Strain61 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Wrinkled
Strain70 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain72 Smooth vs. Smooth Smooth vs. Smooth Wrinkled vs. Smooth
Strain82 Smooth vs. Smooth Smooth vs. Smooth Wrinkled vs. Smooth
Strain85 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain107 Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain06A Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Wrinkled
Strain06L Wrinkled vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Wrinkled
Strain10Li Smooth vs. Smooth Wrinkled vs. Wrinkled Wrinkled vs. Smooth
Strain10S Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
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Table 3 Hypha formation on solid media of Candida albicans clinical isolates obtained from the oral cavity of kidney
transplant recipients (Continued)
Strain12A Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain12L Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain15A Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain15G Wrinkled vs. Wrinkled Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain15L Wrinkled vs. Wrinkled Wrinkled vs. Smooth Wrinkled vs. Wrinkled
Strain18A Smooth vs. Smooth Wrinkled vs. Smooth Wrinkled vs. Smooth
Strain111L Smooth vs. Smooth Smooth vs. Smooth Smooth vs. Smooth
Strain111R Wrinkled vs. Wrinkled Wrinkled vs. Smooth Wrinkled vs. Wrinkled
*CE: Crude Extract of Eugenia uniflora (2000 μg/mL).
The isolates were incubated in triplicates at 30°C for seven days on YPD + 20% FBS, Spider medium and N-acetyl-D-glucosamine agar in the absence (control
experiments) or presence of 2000 μg/ml (test experiments) of the CE of Eugenia uniflora.
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with the formula described below:
Pz ¼ Colony diameter cmð Þ
Colony diameter cmð Þ þ Precipitation zone cmð Þ
Candida albicans proteinase assay
Proteinase activity was determined in the same manner
as described for phospholipase activity, except by the
fact that cells were inoculated on the surface of protein-
ase agar (11,7 g Yeast Carbon Base, 0,1 g Yeast Extract,
2 g Bovine Serum Albumine, CE of E. uniflora 2000 μg/mL,
16 g Agar, Distilled water 800 mL).
Statistical analysis
Data were analyzed using the statistical software “Graph-
Pad”, version 3.0. Results were presented as mean ± standard
deviation, and differences were analyzed by the Mann–
Whitney test. For all the analyses, P was considered a
default value of 0.05 and the confidence interval of
95%.
Results
Micromorphological analysis of Candida albicans grown in
the presence of Eugenia uniflora
The C. albicans reference strains SC5314 and ATCC90028
were pre-cultivated in NGY broth overnight at 30°C added
2000 μg/ml of E. uniflora and subsequently analyzed with
optical microscopy. It was observed that the typical oval
morphological form of C. albicans blastoconidia was al-
tered; showing invaginations of the cell wall and an increase
in the size of citoplasmatic vacuoles with this concentration
of the CE (Figure 1). Therefore 2000 μg/ml was the concen-
tration used to grow C. albicans cells to standardize the
inoculum before all the experiments were performed. Fur-
thermore, we adjusted the inoculum in a manner that
both control (in the absence of E.uniflora) and test (in the
presence of E. uniflora) experiments had the same amountof viable cells (determined by colony forming units counts
after plating the cells on SDA, after 48 h incubation).
Candida albicans hyphal induction in liquid medium
The 48 clinical isolates of C. albicans and the reference
strains ATCC90028 and SC5314 were tested for the ability
to form hyphae in liquid YPD + 20% FBS, Spider and
GlcNac broth after pre-cultivation of the cells in presence
and absence of the CE of E. uniflora. When C. albicans
cells were inoculated in liquid YPD + 20% FBS, the pre-
dominant morphology of the cells (previously grown in
the absence of the CE) was pseudo-hyphae, with a mean
MI ranging from 1.71 (strain 61) to 4.0 (strain 111R), after
hyphal induction (Table 1). However, for the majority of
the strains we observed a reduction in filamentation when
cells were pre-cultivated in the presence of de CE. The
mean MI was reduced in 41 of 50 strains analyzed (82%).
The most notorious inhibition was observed for strain
17. The mean MI of 3.38 in the absence of the CE de-
creased to 1.82 when the cells were pre-cultivated in the
presence of the CE of E. uniflora. In addition, C. albicans
111R, a highly filamentous strain found in our study
(Mean MI = 4 in the absence of the CE of E. uniflora), also
had a reduction in the mean MI in the presence of the CE
(MI = 3.11; Table 1; Figure 2).
The same trend was also observed when C. albicans
strains were inoculated in Spider broth. The mean MI
ranged from 1.64 (strain 61) to 3.85 (strains 111R), with
an average of 2.47 for all the strains. However, a reduc-
tion in the morphology index was observed for all the
isolates when cells were pre-cultivated with the CE of
E. uniflora (mean of 1.37). The most significant reduction
was observed for strain 11, which reduced the mean MI
from 3.62 to 1.05 (reduction of 71%). The isolate 111R, a
highly hyphae forming strain, had a reduction of the mean
MI from 2.21 to 1.21 (45.3%; Table 1; Figure 2).
A possible reduction of the MI was also investigated in
the hyphal inducing medium GlcNac broth. The mean
MI ranged from 1.93 (strain 06) to 3.88 (strain 51), with
Figure 3 Different phenotypes of hypha formation on YPD + 20% FBS agar of Candida albicans clinical isolates obtained from the oral
cavity of kidney transplant recipients. The isolates were incubated in triplicates at 30°C for seven days in the absence (control experiments;
column 1) or presence of 2000 μg/ml (test experiments; column 2) of the CE of Eugenia uniflora.
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Figure 4 Different phenotypes of hypha formation on Spider
medium of Candida albicans clinical isolates obtained from the
oral cavity of kidney transplant recipients. The isolates were
incubated in triplicates at 30°C for seven days in the absence
(control experiments; column 1) or presence of 2000 μg/ml (test
experiments; column 2) of the CE of Eugenia uniflora.
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hyphae. When the isolates were pre-cultivated in the
presence of the CE of E. uniflora, a reduction in the
mean MI was observed for 48 of the 50 strains evalu-
ated, with a mean MI of 1.98. The mean MI of the iso-
late 06 L was markedly reduced when the strain was
pre-cultivated in the presence of CE of E. uniflora (3.86
to 1.13; 70.7%; Table 1). The mean MI for the strain
111R (highly filamentous) was also reduced in the pres-
ence of GlcNac. However, the reduction was not as ex-
pressive as when YPD + 20% FBS and Spider broth were
used as hyphal inducing media (Table 1; Figure 2).
Candida albicans measurments of hyphae lengths
Despite the fact that we could not observe a reduction in
the mean MI for 18% of the strains tested when YPD +
20% FBS was used for hyphal induction, we noticed that
although they were able to form true hyphae, hyphal sizes
were visually shorter. In order to investigate the degree of
reduction of the hyphae lengths, we randomly selected 13
isolates with low, moderate and high mean MI and the
two reference strains after hyphal induction in YPD + 20%
FBS with cells previously grown in the presence of the CE
of E. uniflora. Hyphal sizes were observed with optic
microscopy. We observed a reduction in hyphal size
for all the 16 strains evaluated (including SC5314 and
ATCC90028 reference strains). While the mean hyphal
size was 21μm for the cells pre-cultivated in the ab-
sence of the CE, there was a reduction to 14 μm in the
presence of the CE (Table 2). Hyphal size measure-
ments were not performed with Spider or GlcNac broth
because we could not visually observe length differences
when several cells of each strain were observed in different
microscopy fields.
Candida albicans hyphal induction on solid media
We also evaluated a possible effect of the CE of E. uniflora
in C. albicans hypha formation on solid media by cultivat-
ing all the 48 isolates and the two reference strains for
seven days on YPD + 20% FBS agar, Spider medium and
GlcNac agar medium at 30°C. The macromorphological
aspect of the colonies was observed and the strains were
markedly smoother than the respective control, grown in
the absence of the CE, which showed wrinkled colonies
(Table 3; Figures 3, 4 and 5). Despite the fact that YPD
agar added 20% FBS was not an efficient inducer of fila-
mentation for most of the isolates tested, for the strains
Figure 5 Different phenotypes of hypha formation on N-acetyl-D-glucosamine of Candida albicans clinical isolates obtained from the
oral cavity of kidney transplant recipients. The isolates were incubated in triplicates at 30°C for seven days in the absence (control
experiments; column 1) or presence of 2000 μg/ml (test experiments; column 2) of the crude extract of Eugenia uniflora.
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Table 4 Hydrolytic enzymes activity on solid media of
Candida albicans clinical isolates obtained from the oral
cavity of kidney transplant recipients
Proteinase Activity (Pz†) Phospholipase Activity
(Pz†)
Strain Absence of CE** vs.
Presence of CE**
Absence of CE** vs.
Presence of CE**
ATCC90028 0.47 ± 0.03 vs. 1 ± 0.00* 0.80 ± 0.11 vs. 1 ± 0.00*
SC5314 0.59 ± 0.10 vs. 1 ± 0.00* 0.59 ± 0.04 vs. 1 ± 0.00*
Strain01 0.36 ± 0.04 vs. 1 ± 0.00* 0.55 ± 0.08 vs. 1 ± 0.00*
Strain02 0.51 ± 0.02 vs. 1 ± 0.00* 0.68 ± 0.02 vs. 1 ± 0.00*
Strain03 1 ± 0.00 vs. 1 ± 0.00 1 ± 0.00 vs. 1 ± 0.00
Strain05 0.29 ± 0.01 vs. 0.88 ± 0.01* 0.64 ± 0.00 vs. 1 ± 0.00*
Strain06 0.72 ± 0.11 vs. 1 ± 0.00* 0.60 ± 0.00 vs. 1 ± 0.00*
Strain08 0.72 ± 0.02 vs. 1 ± 0.00* 0.57 ± 0.00 vs. 1 ± 0.00*
Strain10 1 ± 0.00 vs. 1 ± 0.00 1 ± 0.00 vs. 1 ± 0.00
Strain11 0.43 ± 0.01 vs. 1 ± 0.00* 0.63 ± 0.04 vs. 1 ± 0.00*
Strain12 0.31 ± 0.02 vs. 1 ± 0.00* 0.75 ± 0.00 vs. 1 ± 0.00*
Strain13 0.69 ± 0.02 vs. 1 ± 0.00* 0.59 ± 0.01 vs. 1 ± 0.00*
Strain17 0.74 ± 0.02 vs. 1 ± 0.00* 0.50 ± 0.03 vs. 1 ± 0.00*
Strain20 0.61 ± 0.11 vs. 1 ± 0.00* 0.55 ± 0.03 vs. 1 ± 0.00*
Strain21 0.63 ± 0.02 vs. 1 ± 0.00* 0.58 ± 0.07 vs. 1 ± 0.00*
Strain23 0.65 ± 0.05 vs. 1 ± 0.00* 0.67 ± 0.04 vs. 1 ± 0.00*
Strain24 0.67 ± 0.12 vs. 1 ± 0.00* 0.49 ± 0.02 vs. 1 ± 0.00*
Strain28 0.44 ± 0.02 vs. 1 ± 0.00* 0.55 ± 0.05 vs. 1 ± 0.00*
Strain30 0.27 ± 0.05 vs. 1 ± 0.00* 0.68 ± 0.04 vs. 1 ± 0.00*
Strain31 0.47 ± 0.02 vs. 1 ± 0.00* 0.52 ± 0.02 vs. 1 ± 0.00*
Strain32 0.42 ± 0.04 vs. 1 ± 0.00* 0.75 ± 0.06 vs. 1 ± 0.00*
Strain34 0.75 ± 0.00 vs. 1 ± 0.00* 0.73 ± 0.03 vs. 1 ± 0.00*
Strain37 0.60 ± 0.06 vs. 1 ± 0.00* 0.50 ± 0.03 vs. 1 ± 0.00*
Strain40 0.53 ± 0.06 vs. 1 ± 0.00* 0.58 ± 0.05 vs. 1 ± 0.00*
Strain41 0.76 ± 0.10 vs. 1 ± 0.00* 0.55 ± 0.02 vs. 1 ± 0.00*
Strain44 1 ± 0.00 vs. 1 ± 0.00 0.64 ± 0.03 vs. 1 ± 0.00*
Strain46 0.57 ± 0.04 vs. 1 ± 0.00* 0.65 ± 0.02 vs. 1 ± 0.00*
Strain50 0.54 ± 0.03 vs. 1 ± 0.00* 0.63 ± 0.11 vs. 1 ± 0.00*
Strain51 0.39 ± 0.03 vs. 1 ± 0.00* 0.53 ± 0.00 vs. 1 ± 0.00*
Strain53 0.36 ± 0.04 vs. 1 ± 0.00* 0.37 ± 0.05 vs. 1 ± 0.00*
Strain54 0.37 ± 0.06 vs. 1 ± 0.00* 0.57 ± 0.03 vs. 1 ± 0.00*
Strain60 0.28 ± 0.00 vs 0.88 ± 0.00* 0.55 ± 0.04 vs. 1 ± 0.00*
Strain61 1 ± 0.00 vs. 1 ± 0.00 0.5 ± 0.03 vs. 1 ± 0.00*
Strain70 0.39 ± 0.05 vs. 1 ± 0.00* 0.76 ± 0.08 vs. 1 ± 0.00*
Strain72 0.30 ± 0.01 vs. 1 ± 0.00* 0.62 ± 0.02 vs. 1 ± 0.00*
Strain82 0.38 ± 0.05 vs. 1 ± 0.00* 0.50 ± 0.06 vs. 1 ± 0.00*
Strain85 0.40 ± 0.03 vs. 1 ± 0.00* 1 ± 0.00 vs. 1 ± 0.00
Strain107 1 ± 0.00 vs. 1 ± 0.00 0.54 ± 0.01 vs. 1 ± 0.00*
Strain06A 0.28 ± 0.02 vs. 1 ± 0.00* 1 ± 0.00 vs. 1 ± 0.00
Strain06L 0.45 ± 0.03 vs. 1 ± 0.00* 0.56 ± 0.00 vs. 1 ± 0.00*
Table 4 Hydrolytic enzymes activity on solid media of
Candida albicans clinical isolates obtained from the oral
cavity of kidney transplant recipients (Continued)
Strain10Li 0.59 ± 0.03 vs. 1 ± 0.00* 0.52 ± 0.02 vs. 1 ± 0.00*
Strain10S 0.31 ± 0.04 vs. 1 ± 0.00* 0.79 ± 0.04 vs. 1 ± 0.00*
Strain12A 0.72 ± 0.05 vs. 1 ± 0.00* 0.50 ± 0.00 vs. 1 ± 0.00*
Strain12L 0.56 ± 0.02 vs. 1 ± 0.00* 0.55 ± 0.02 vs. 1 ± 0.00*
Strain15A 0.75 ± 0.00 vs. 1 ± 0.00* 0.51 ± 0.00 vs. 1 ± 0.00*
Strain15G 0.44 ± 0.07 vs. 1 ± 0.00* 0.54 ± 0.02 vs. 1 ± 0.00*
Strain15L 0.42 ± 0.02 vs. 1 ± 0.00* 0.47 ± 0.03 vs. 1 ± 0.00*
Strain18A 0.4 ± 0.00 vs. 1 ± 0.00* 0.52 ± 0.03 vs. 1 ± 0.00*
Strain111L 0.29 ± 0.01 vs. 1 ± 0.00* 0.67 ± 0.04 vs. 1 ± 0.00*
Strain111R 0.42 ± 0.02 vs. 1 ± 0.00* 0.68 ± 0.02 vs. 1 ± 0.00*
*P < 0.05, **CE: Crude Extract of Eugenia uniflora (2000μg/mL); †
Pz = Precipitation zone.
The isolates were incubated in triplicates at 30°C for 72 h on proteinase or
phospholipase agar in the absence (control experiments) or presence of 2000
μg/ml (test experiments) of the CE of Eugenia uniflora.
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tion, smooth colonies were also observed for the respect-
ive strain grown in the presence of the CE of E. uniflora
(Figure 3).
Effect of CE of Eugenia uniflora in secretion of hydrolytic
enzymes
Other important virulence attribute of C. albicans is the
ability to secrete hydrolytic enzymes. Therefore, we eval-
uated phospholipase and proteinase activity of the 48
clinical isolates of C. albicans and the references strains
ATCC90028 and SC5314. When cells were grown on the
surface of egg yolk emulsion agar (phospholipase induc-
tion), the average phospholipase zone values for all the
50 strains was 0.54 ± 0.18, considered a moderate activity
(Table 4). When the CE of E. uniflora was included in
the phospholipase media, the activity was completely
inhibited (Figure 6). The same trend was observed for
cells grown on the surface of the proteinase induction
medium without the CE of E. uniflora. All the strains
were able to produce satisfactory levels of proteinase
(mean Pz value of 0.44 ± 0.21). A total inhibition of pro-
teinase activity was observed for 48 out of 50 isolates of
C. albicans, including the reference strains (Figure 7). In
fact, only two strains (05 and 60; 4%) were still able to
produce very low amounts of the hydrolytic enzyme
(Pz of 0.88 ± 0.01 and 0.88 ± 0.00, respectively; Table 4).
Discussion
In this study we investigated a possible role of the CE of
E. uniflora in some virulence factors of C. albicans. In a
previous study performed by Ferreira et al. [43], a
screening of antifungal activity of medicinal plants from
northeastern Brazil, including 30 different vegetal CEs,
Figure 6 Phospholipase activity on solid media of Candida albicans clinical isolates obtained from the oral cavity of kidney transplant
recipients. The isolates were incubated in triplicates at 30°C for 72 h on phospholipase agar in the absence (control experiments; A) or presence
of 2000 μg/ml (test experiments; B) of the crude extract of Eugenia uniflora.
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with minimal inhibitory concentration (MIC) values ran-
ging from 31.25 to 62.5 μg/mL against C. albicans, as
determined by broth microdilution methodology.
After the observation of C. albicans cells growth inhib-
ition with the CE of E. uniflora, we decided to investi-
gate a possible action of this natural product in the
impairment of the full expression of some virulence fac-
tors in C. albicans. Therefore, we have used NGY broth
to grow our strains in the presence of the CE previously
to each attribute of virulence tested in vitro. We hypoth-
esized that when growing our strains in the presence of
this natural product, C. albicans cells would be impaired
to fully express the pathogenicity factors investigated.
Therefore a pilot experiment revealed that 2000 μg/ml
of the E. uniflora CE was needed to inhibit approxi-
mately 50% growth of cells incubated for 18 to 24 h in
NGY broth under 200 rpm, 30°C, but not to kill all of
them. Of note, this is a complete different condition
compared to the MIC determination experiment per-
formed by Ferreira et al. [43], where the cells wereFigure 7 Proteinase activity on solid media of Candida albicans clinica
recipients. The isolates were incubated in triplicates at 30°C for 72 h on pr
2000 μg/ml (test experiments; B) of the crude extract of Eugenia uniflora.incubated statically, in RPMI-1640, also in a different
volume of culture medium. In our study, C. albicans
cells were grown in NGY broth, 200 rpm. Incubation
condition differences may explain discrepant MIC values
within the two different methodologies.
When C. albicans cells were cultivated overnight in
the presence of the natural product, bud cells demon-
strated alterations in the cellular structure, suggesting
a possible action of the CE of E. uniflora specifically
on C. albicans cell wall.
It has been described that vegetal extracts can act on
the cell wall of C. albicans. By analyzing the mechanism
of action of the vegetal extract of Stryphnodendron
adstringens on C. albicans cells, Ishida et al. [35] ob-
served that the integrity of the cell wall was damaged,
with the presence of several deformations in buddy cells
structure.
It is important to emphasize that the recently devel-
oped antifungal drugs named echinocandins target Can-
dida and Aspergillus cell wall, by inhibiting the enzyme
β-1,3-D-glucan synthase [46]. These chemical compoundsl isolates obtained from the oral cavity of kidney transplant
oteinase agar in the absence (control experiments; A) or presence of
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malian cholesterol. Therefore, if E. uniflora compounds
are truly acting on the cell wall, the natural product may
be used for future development of antifungal drugs with
lower side effects.
Bud-to-hyphae transition of C. albicans is a funda-
mental step for the establishment of infection, contribut-
ing to tissue invasion. We found that the ability to form
true hyphae was reduced for the majority of isolates. Be-
sides, all of the strains tested had a reduction in hyphal
size in YPD + 20% FBS, when previously grown with the
CE of E. uniflora. Of note, shorter true hyphae were not
observed when C. albicans cells were incubated in liquid
Spider medium and GlcNac liquid media, when previ-
ously grown in the presence of the CE. This may be ex-
plained because serum is the most potent inducer of
hypha formation resulting in cells with higher MI [20].
Thus, due to the fact that the other two hyphal inducers
already produced shorter true hyphae in C. albicans, a
decrease in hyphal size could not be observed when cells
were grown in the presence of the natural product.
Although others have found that natural products may
impair morphogenesis [34,47,48], in our study we ana-
lyzed a higher number of strains and generated quantita-
tive data of decreased hypha formation, under different
bud-to-hyphae transition inducing media.
When C. albicans cells suspension were plated on the
surface of Spider medium, GlcNac agar and YPD + 20%
FBS agar, several phenotypic filamentous colonies were
observed. When the CE of E. uniflora was added in the
composition of the three media, it was observed a no-
torious reduction of filamentation of the colonies. Simi-
lar results were observed by Tsang et al. [34], who
investigated the role of purpurin, a compound derived
from Rubia tinctorum L. roots, in the impairment of fila-
mentation of C. albicans on solid Spider medium.
Other important aspect of our findings is that the CE
of E. uniflora clearly affects bud-to-hypha transition, ob-
served under three different conditions. It is well known
that morphogenesis in C. albicans can be triggered by
the stimulation of several pathways or by essentially a
single pathway, which is fully activated [49].
The secretion of hydrolytic enzymes such as protein-
ase and phospholipase are important virulence factors of
C. albicans, contributing for the establishment of infec-
tion by damaging tissues and cellular membrane [25,50].
When the CE of E. uniflora was added to phospholipase
and proteinase media, the zone of activity of the en-
zymes was either highly reduced or completely inhibited.
This is an important finding because a reduction of pro-
duction and secretion of these enzymes are related with
a decrease of C. albicans virulence [51].
To the best of our knowledge, this is the first report in
literature where the action of a natural product obtainedfrom a plant is impairing the expression of both en-
zymes. The effect of the CE of Dodonaea viscosa var.
angustifolia leaves, an indigenous South African plant,
on proteinase and phospholipase activity in C. albicans
was investigated in 26 strains isolated from the oral cav-
ity of 150 HIV patients. Nevertheless, the secretion of
both enzymes was not affected by the addition of the
plant extract [52].
Conclusions
This was the first study to deeply investigate the effect of
the CE of E. uniflora in virulence factors of C. albicans
clinical isolates collected in a specific clinical scenario
(oral candidiasis in kidney transplant recipients). Our
study has proved a satisfactory effect of this natural prod-
uct in inhibiting three important virulence factors of
C. albicans. We also verified that more than 80% of
A549 cells (human alveolar basal epithelial cell line)
remained viable even when exposed to 4 fold concen-
tration of the CE of E. uniflora (8000 μg/ml; unpub-
lished data), suggesting its possible safety if applied as
an antifungal agent in the future. Our group is cur-
rently working on the elucidation of the chemical
compounds responsible for the inhibition of growth
and specifically interactions with virulence factors.
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